Epizyme, Inc. (EPZM): Price and Financial Metrics
EPZM Price/Volume Stats
| Current price | $1.47 | 52-week high | $5.80 |
| Prev. close | $1.49 | 52-week low | $0.41 |
| Day low | $1.47 | Volume | 22,276,000 |
| Day high | $1.50 | Avg. volume | 3,225,203 |
| 50-day MA | $1.21 | Dividend yield | N/A |
| 200-day MA | $1.80 | Market Cap | 247.44M |
EPZM Stock Price Chart Interactive Chart >
Epizyme, Inc. (EPZM) Company Bio
Epizyme, Inc. discovers and develops epigenetic therapies for cancer patients. The company was founded in 2007 and is based in Cambridge, Massachusetts.
EPZM Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -51.32% |
| 5-year | -92.86% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | -76.98% |
| 2020 | -55.85% |
| 2019 | 299.35% |
Continue Researching EPZM
Want to see what other sources are saying about Epizyme Inc's financials and stock price? Try the links below:Epizyme Inc (EPZM) Stock Price | Nasdaq
Epizyme Inc (EPZM) Stock Quote, History and News - Yahoo Finance
Epizyme Inc (EPZM) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...